Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

BIOVENTUS ($BVS) Releases Q4 2025 Earnings

None

BIOVENTUS ($BVS) posted quarterly earnings results for Q4 2025 on Thursday, March 5th. The company reported earnings of $0.24 per share, beating estimates of $0.22 by $0.02. The company also reported revenue of $157,900,000, beating estimates of $156,395,470 by $1,504,530.

You can see Quiver Quantitative's $BVS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

BIOVENTUS Insider Trading Activity

BVS Insider Trades

BIOVENTUS insiders have traded $BVS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $BVS stock by insiders over the last 6 months:

  • MICHELLE MCMURRY-HEATH sold 17,701 shares for an estimated $131,254
  • GUY P NOHRA sold 10,000 shares for an estimated $75,658

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BIOVENTUS Hedge Fund Activity

We have seen 84 institutional investors add shares of BIOVENTUS stock to their portfolio, and 70 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BIOVENTUS Government Contracts

We have seen $19,980 of award payments to $BVS over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles